Clinical Trials on Enterocolitis, Neutropenic in Norway
Total 7 results
-
Genzyme, a Sanofi CompanyCompletedDiarrhea | Clostridium EnterocolitisAustralia, Belgium, France, Spain, Germany, Portugal, Switzerland, Austria, United Kingdom, Ireland, Czech Republic, Denmark, Norway, Sweden
-
Coloplast A/SCompletedNeurogenic Bladder Dysfunction NosDenmark, France, Germany, Norway, Sweden
-
Sunnaas Rehabilitation HospitalUniversity of Oslo; SINTEF MiNaLabCompletedCystometry Using a Novel Microsensor System in Patients With Neurogenic Bladder Dysfunction (PEPRE2)Spinal Cord Injuries | Urinary Bladder, NeurogenicNorway
-
Dentsply InternationalWellspect HealthCareCompletedNeurogenic BowelDenmark, France, Germany, Italy, Norway, Spain, Sweden, United Kingdom
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive Bladder | Pharmacokinetics of Mirabegron | Neurogenic Detrusor OveractivityBelgium, Denmark, Norway, Poland, Serbia
-
Astellas Pharma Europe B.V.CompletedNeurogenic Detrusor OveractivityBelgium, Croatia, Turkey, Australia, Denmark, Israel, Jordan, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Norway, Philippines, Poland, Romania, Serbia, Slovakia, Taiwan
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedAnemia | Lung Cancer | Neutropenia | Drug/Agent Toxicity by Tissue/OrganUnited States